1. Home
  2. ABCL vs WRBY Comparison

ABCL vs WRBY Comparison

Compare ABCL & WRBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$12.61

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Logo Warby Parker Inc.

WRBY

Warby Parker Inc.

HOLD

Current Price

$23.61

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABCL
WRBY
Founded
2012
2010
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Ophthalmic Goods
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.1B
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
ABCL
WRBY
Price
$12.61
$23.61
Analyst Decision
Strong Buy
Buy
Analyst Count
5
11
Target Price
$8.40
$27.10
AVG Volume (30 Days)
4.4M
2.4M
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
10.91
105.88
EPS
N/A
0.06
Revenue
$75,128,000.00
$871,905,000.00
Revenue This Year
N/A
$14.48
Revenue Next Year
$21.85
$16.41
P/E Ratio
N/A
$387.50
Revenue Growth
160.56
13.04
52 Week Low
$2.75
$14.96
52 Week High
$13.18
$31.00

Technical Indicators

Market Signals
Indicator
ABCL
WRBY
Relative Strength Index (RSI) 65.97 42.76
Support Level $10.38 $21.13
Resistance Level N/A $30.60
Average True Range (ATR) 0.61 1.23
MACD -0.01 -0.09
Stochastic Oscillator 79.02 27.08

Price Performance

Historical Comparison
ABCL
WRBY

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

About WRBY Warby Parker Inc.

Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The Company provides holistic vision care by offering eyewear, contacts, and eye care directly to consumers through its integrated, omnichannel platform. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.

Share on Social Networks: